Previous 10 | Next 10 |
Zynex Ranks 11th in Forbes List of "America's Best Small Companies 2023" PR Newswire ENGLEWOOD, Colo. , Dec. 22, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI ) , an innovative medical technology company specializing in the manufacture and sale...
Summary Two new Breakout Stocks for Week 50 with better than 10% short-term upside potential and one Dow 30 Pick. Average cumulative returns now up to +131.5% YTD. This week 1 of 4 high frequency breakout picks gained over 10% in less than a week with peak gains in VITL +10.4% while PBT...
Zynex Medical to Participate in Piper Sandler 34th Annual Healthcare Conference PR Newswire ENGLEWOOD, Colo. , Nov. 21, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and...
Zynex Named as a Winner in the Deloitte 2022 Technology Fast 500TM Awards for the 4th Consecutive Year PR Newswire ENGLEWOOD, Colo. , Nov. 17, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI ), an innovative medical technology company speciali...
Summary Two new Breakout Stocks for Week 46 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now up to +116.9% YTD. This week two picks gained 10% in less than a week with MAG +14.9% and CLNE +15.4% for total portfolio gains over 5%. ...
Zynex ( NASDAQ: ZYXI ) shares gained 3% Tuesday morning after the medical technology company announced an additional $10M share buyback authorization. The program will commence on Nov. 1, 2022 and is scheduled to terminate on Oct. 31, 2023 or when the $10.0 million buy...
At the heart of the medical device space isn’t just new technologies for diagnostics but also substitutes for potentially addictive and life-destroying drugs. Anything you can do with physical-external stimuli instead of pills that impact the brain is possibly a life-changing option fo...
Zynex, Inc. (ZYXI) Q3 2022 Earnings Conference Call October 27, 2022 4:15 AM ET Company Participants Louisa Smith – Investor Relations-Gilmartin Group Thomas Sandgaard – Chairman, President and Chief Executive Officer Dan Moorhead – Chief Fin...
Zynex press release ( NASDAQ: ZYXI ): Q3 GAAP EPS of $0.13. Revenue of $41.52M (+19.3% Y/Y). Q4 2022 Guidance: The estimated range for fourth quarter 2022 revenue is between $48-$51 million, an increase of approximately 23% from Q4 2021. Adjusted EBITDA for the fou...
Zynex Announces 2022 Third Quarter Earnings PR Newswire ENGLEWOOD, Colo. , Oct. 27, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Zynex Inc CEO Thomas Sandgaard joined Steve Darling from Proactive to announce the company's financial and operational results for the second quarter ending June 30, 2024, in an interview with Proactive. The company achieved a remarkable 20% year-over-year increase in orde...
2024-07-26 16:37:00 ET Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical equipment company reported earnings last night that, on a headl...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...